Clicky

CRISPR Therapeutics AG(CRSP) News

Date Title
Jun 4 BEAM Up on FDA's Orphan Drug Status for Gene-Editing Therapy
Jun 4 Can CRISPR Build on Casgevy's Success With Its In Vivo Pipeline?
Jun 3 The Best Stocks to Invest $1,000 in Right Now
Jun 2 The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip
May 29 CRISPR Therapeutics to Participate in Upcoming Investor Conferences
May 21 Crispr Therapeutics call volume above normal and directionally bullish
May 21 3 Top Genomics Stocks to Add to Your Portfolio in 2025
May 21 CRISPR Therapeutics AG (CRSP) Strikes $95M Deal with Sirius to Develop Blood Clot Drug
May 20 CRISPR Therapeutics Inks Collaboration Deal to Develop siRNA Therapies
May 20 5 Monster Stocks to Hold for the Next 10 Years
May 20 CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?
May 19 CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies
May 18 Prediction: This Beaten-Down Stock Could Double in The Next 5 Years
May 14 Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?
May 13 2 Biotech Stocks That Are Screaming Buys in May
May 12 Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?
May 10 3 Monster Stocks to Hold for the Next 10 Years
May 8 CRISPR Therapeutics (NasdaqGM:CRSP) Q1 2025 Revenue Increases 71% to US$1 Million
May 8 Brokers Suggest Investing in CRISPR Therapeutics (CRSP): Read This Before Placing a Bet
May 8 CRISPR Therapeutics First Quarter 2025 Earnings: Misses Expectations